Genome Editing and Future-Report

Ever since the discovery of the DNA, several technologies have evolved to genetically manipulate the organisms for the better agricultural and industrial applications. The next generation sequencing techniques have made the identification of the different genes and mutations in DNA easier. The GMOs and cloning techniques which are in use for a significant time now are the direct result of the advancement in this domain. These cloning techniques are being exploited for a wide array of medical, agricultural, industrial and research applications for past several decades. However, despite all the development and progress there is a constant need for more advanced gene editing techniques that are precise and accurate. The use of programmable nucleases for genetic modifications has increased in past decade for its potential to treat various inheritable diseases and cancer. In past decade three major classes of programmable nucleases have come to light– the zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and the clustered regularly interspaced short palindromic repeats (CRISPR)–associated Cas9 (CRISPR/Cas9).

Report

Genome Editing and Future

Genome Editing and Future

Download the Report

Send download link to:

About TTC
We’ve constantly identified the value of new technology carried out by our pretty skilled executive crew with backgrounds as our professionals. Like the IP professionals we empower, our starvation for development is never-ending. We IMPROVISE, ADAPT, and IMPLEMENT in a strategic manner.
 
You also can Contact Us to set up a consultation.
 
TT Consultants offers a range of efficient, high-quality solutions for your intellectual property management ranging from Patentability Search, Invalidation Search, FTO (Freedom to Operate), Patent Portfolio Optimization, Patent Monitoring, Patent Infringement Search, Patent Drafting & Illustrations, and much more. We provide both law firms and corporations in many industries with turnkey solutions.
Insights

More Related Articles

Biosimilars Market Report: Trends, Opportunities & Insights

How the USPTO’s AI Inventorship Reset Changes Patent Portfolio Strategy for Companies Building with Generative AI

Ex Parte Injunctions in Patent Cases: What the Courts’ Cautious New Standard Means for Product Launches

Switzerland Is Revising Its Patent Act: What the Incoming Reforms Mean for Patent Landscape Strategy